Inventor · disambiguated record
Robert F. Halenbeck
Also filed as: HALENBECK ROBERT · HALENBECK ROBERT F · HALENBECK ROBERT FORGAN
43 granted patents·5 pending applications·2,025 citations·filing 1984–2013
98Inventor score
Top patents by PatentIndex Score
48 records- 0196US5206344AInterleukin-2 muteins and polymer conjugation thereofCETUS ONCOLOGY CORP·Filed 1988·Granted Apr 27, 1993·948 cites·12 claims
- 0295US5116943AOxidation-resistant muteins of Il-2 and other proteinCETUS CORP·Filed 1988·Granted May 26, 1992·230 cites·13 claims
- 0395US4572798AMethod for promoting disulfide bond formation in recombinant proteinsCETUS CORP·Filed 1984·Granted Feb 25, 1986·119 cites·19 claims
- 0491US4752585AOxidation-resistant muteinsCETUS CORP·Filed 1986·Granted Jun 21, 1988·91 cites·12 claims
- 0586US4929700AProduction of purified, biologically active, bacterially produced recombinant human CSF-1CETUS CORP·Filed 1988·Granted May 29, 1990·101 cites·41 claims
- 0685US5104975ACompositions for detecting ras gene proteins and cancer therapeuticsCETUS CORP·Filed 1988·Granted Apr 14, 1992·48 cites·18 claims
- 0781US5866114ACrystallization of M-CSFαCHIRON CORP·Filed 1993·Granted Feb 2, 1999·52 cites·42 claims
- 0879US5234839ACompositions for detecting ras gene proteins and cancer therapeuticsCETUS ONCOLOGY CORP·Filed 1991·Granted Aug 10, 1993·47 cites·8 claims
- 0978USRE35171ECompositions for detecting ras gene proteins and cancer therapeuticsCETUS ONCOLOGY CORP·Filed 1994·Granted Mar 5, 1996·36 cites·18 claims
- 1078US4931543AProcess for recovering microbially produced interleukin-2CETUS CORP·Filed 1988·Granted Jun 5, 1990·38 cites·17 claims
- 1177US6323326B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1996·Granted Nov 27, 2001·31 cites·69 claims
- 1276US5573930ADNA encoding various forms of colony stimulating factor-1CETUS ONCOLOGY CORP·Filed 1992·Granted Nov 12, 1996·31 cites·17 claims
- 1375US7226757B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Jun 5, 2007·1 cites·31 claims
- 1474US7186530B1Protein associated with cell stress responseCHIRON CORP·Filed 2000·Granted Mar 6, 2007·2 cites·15 claims
- 1572US8575312B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2012·Granted Nov 5, 2013·2 cites·11 claims
- 1672US5491065AMonoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSFCETUS ONCOLOGY CORP·Filed 1993·Granted Feb 13, 1996·36 cites·10 claims
- 1766US5965382ANucleic acid encoding secreted Mac-2 binding glycoproteinCHIRON CORP·Filed 1994·Granted Oct 12, 1999·13 cites·22 claims
- 1865US6319896B1Method of solubilizing, purifying, and refolding proteinCHIRON CORP·Filed 1999·Granted Nov 20, 2001·15 cites·24 claims
- 1965US5998378ACompositions for the inhibition of TNF hormone formation and uses thereofCHIRON CORP·Filed 1994·Granted Dec 7, 1999·28 cites·14 claims
- 2064US6204020B1DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereofCHIRON CORP·Filed 1995·Granted Mar 20, 2001·12 cites·10 claims
- 2164US5643563AN-∇3 deletion mutants of the short form of CSF-1CHIRON CORP·Filed 1995·Granted Jul 1, 1997·12 cites·14 claims
- 2263US8178109B2Compositions and methods of use for MGD-CSF in disease treatmentBEHRENS DIRK·Filed 2009·Granted May 15, 2012·0 cites·12 claims
- 2363US5681719ADNA encoding N- and C- terminally truncated colony stimulating factor-1 variantsCHIRON CORP·Filed 1995·Granted Oct 28, 1997·11 cites·27 claims
- 2462US2007128710A1Novel protein associated with cell stress responseCHIRON CORP A DELAWARE CORP·Filed 2007·Application pending·0 cites
- 2561US7022672B2Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitorSEARLE LLC·Filed 2001·Granted Apr 4, 2006·1 cites·85 claims
- 2659US6322779B1Recombinant human CSF-1 dimer and compositions thereofCHIRON CORP·Filed 1995·Granted Nov 27, 2001·18 cites·14 claims
- 2759US2008281084A1Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway InhibitorNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 2858US6146851ADNA encoding NV2 (long form) and carboxy truncated fragments thereofCHIRON CORP·Filed 1995·Granted Nov 14, 2000·10 cites·10 claims
- 2957US6117422AN∇2-CSF-1(long form) and carboxy truncated fragments thereofCHIRON CORP·Filed 1995·Granted Sep 12, 2000·14 cites·18 claims
- 3057US6069127ASecreted mac-2-binding glycoproteinCHIRON CORP·Filed 1995·Granted May 30, 2000·9 cites·7 claims
- 3157US5644035AMethod for purifying secreted Mac-2-binding glycoproteinCHIRON CORP·Filed 1995·Granted Jul 1, 1997·10 cites·2 claims
- 3257US2014170145A1Compositions and methods of use for mgd-csf in disease treatmentFIVE PRIME THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3353US6103224AN∇2 CSF-1 (short form) and carboxy truncated fragments thereofCHIRON CORP·Filed 1995·Granted Aug 15, 2000·11 cites·11 claims
- 3453US4569913AP. obtusus pyranose-2-oxidase preparationCETUS CORP·Filed 1984·Granted Feb 11, 1986·9 cites·6 claims
- 3551US2007264277A1Compositions and Methods of Use for Mgd-Csf in Disease TreatmentBEHRENS DIRK·Filed 2005·Application pending·0 cites
- 3644US6025146AIdentification of M-CSF agonists and antagonistsCHIRON CORP·Filed 1995·Granted Feb 15, 2000·13 cites·8 claims
- 3743US5861150ARecombinant human CSF-1 dimer and compositions thereofCHIRON CORP·Filed 1995·Granted Jan 19, 1999·5 cites·20 claims
- 3843US5651963AHeterodimers forms of CSF-1 and pharmaceutical compositions thereofCHIRON CORP·Filed 1994·Granted Jul 29, 1997·4 cites·10 claims
- 3943US4569910AMethods and reagents for pyranosone productionCETUS CORP·Filed 1984·Granted Feb 11, 1986·4 cites·45 claims
- 4042US2008286834A1Leader Sequences For Directing Secretion of Polypeptides and Methods For Production ThereofHALENBECK ROBERT FORGAN·Filed 2006·Application pending·0 cites
- 4137US5672343AN- 3 deletion mutants of the long form of CSF-1CHIRON CORP·Filed 1995·Granted Sep 30, 1997·1 cites·15 claims
- 4235US6599706B1Recombinant PR-3 and assays employing the sameCHIRON CORP·Filed 1995·Granted Jul 29, 2003·3 cites·6 claims
- 4335US5843693AAssay method for screening for inhibitors of proTNF conversionCHIRON CORP·Filed 1995·Granted Dec 1, 1998·3 cites·2 claims
- 4434US4568645AFungal pyranose-2-oxidase preparationsCETUS CORP·Filed 1984·Granted Feb 4, 1986·3 cites·6 claims
- 4532US6586222B1Recombinant PR-3 and compositions thereofCHIRON CORP·Filed 1995·Granted Jul 1, 2003·1 cites·29 claims
- 4632US5736340ASecreted Mac-2-binding glycoproteinCHIRON CORP·Filed 1995·Granted Apr 7, 1998·0 cites·2 claims
- 4730US5830684ANative type II GAP, methods for purifying various GAPs and uses of GAPs to diagnose cancerCHIRON CORP·Filed 1990·Granted Nov 3, 1998·2 cites·7 claims
- 4829US6156300APoint mutants of N∇2 CSF-1 and carboxy truncated fragments thereofCHIRON CORP·Filed 1995·Granted Dec 5, 2000·0 cites·43 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →